Release 5

This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Example MedicationRequest/medrx0317 (Narrative)

Pharmacy Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Encounter, Patient, Practitioner

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationRequest.

Generated Narrative: MedicationRequest

Resource MedicationRequest "medrx0317"

identifier: id: 12345689 (use: OFFICIAL)

status: completed

intent: order

Medications

-Reference
*

code: Alemtuzumab 10mg/ml (Lemtrada) (RxNorm#1594660)

subject: Patient/pat1: Donald Duck "Donald DUCK"

authoredOn: 2015-01-15

requester: Practitioner/f007: Patrick Pump "Simone HEPS"

Reasons

-Concept
*Chronic Lymphoid Leukemia (disorder) (SNOMED CT#92814006)

dosageInstruction

sequence: 1

text: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction: Rapidly increase dose until tolerated (), Administer on alternate days ()

timing: Duration 12weeks, 3 per 1 weeks

route: Intravenous route (qualifier value) (SNOMED CT#47625008)

method: Inject - dosing instruction imperative (qualifier value) (SNOMED CT#422145002)

doseAndRate

dosageInstruction

sequence: 2

text: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction: Rapidly increase dose until tolerated (), Administer on alternate days ()

timing: Duration 12weeks, 3 per 1 weeks

route: Intravenous route (qualifier value) (SNOMED CT#47625008)

method: Inject - dosing instruction imperative (qualifier value) (SNOMED CT#422145002)

doseAndRate

dosageInstruction

sequence: 3

text: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction: Rapidly increase dose until tolerated (), Administer on alternate days ()

timing: Duration 12weeks, 3 per 1 weeks

route: Intravenous route (qualifier value) (SNOMED CT#47625008)

method: Inject - dosing instruction imperative (qualifier value) (SNOMED CT#422145002)

doseAndRate

 

Other examples that reference this example:

  • MedicationAdministration/IV Admin Not Given
  • MedicationDispense/IV Chemo

    •  

    Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.